Antidepressants for neuroenhancement in healthy individuals: a systematic review
Poiesis and Praxis 6 (3-4):139-174 (2008)
| Abstract | Neuroenhancement offers the prospect of improving the cognitive, emotional and motivational functions of healthy individuals. Of all the conceivable interventions, psychopharmacology provides the most readily available ones, such as antidepressants which are thought to make people better than well . However, up until now, whether they possess such an enhancing ability remains controversial and therefore in this systematic review we will evaluate the effect and safety of modern antidepressants in healthy individuals. A search of MEDLINE and EMBASE databases and cross-references was carried out and the pharmaceutical industry was contacted for suitable data. Trials published in any language through the third week of July 2007 were regarded. Included were single or double blind randomised or quasi-randomised controlled trials that compared a placebo to one or more of the following antidepressants: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, moclobemide, paroxetine, reboxetine, sertraline or venlafaxine in any dose or dosing schedule. Eligible studies were those involving healthy people of any age and either sex who showed no evidence of a psychiatric disorder, cognitive decline or other disease. One hundred thirty-five articles met our inclusion criteria reporting single dose trials and trials with repeated drug administration. Sixty-five of these articles were eligible for a statistical analysis. Based on a linear mixed model, a meta-analysis and a fixed effects meta-regression were performed. Pooling of results by meta-analysis was stratified by the outcome measures (a) mood, (b) emotional processing, (c) wakefulness, (d) attention, (e) memory, and (f) executive functions. On a significance level of p < 0.05 the following significant results emerged: After a single dose of an antidepressant, a significant effect was shown in two of the analysed outcomes. Firstly, there was a small yet significant negative effect on wakefulness. On memory, a positive effect after several measurements was found, but this result could be traced to the results of the one study out of all included studies, which had that many assessment points. The analysis of trials with repeated drug administration (mean duration 14 days, standard deviation 9) yielded the following effects: on mood, a non-significant positive effect was detected that was continuously increasing and reached significance at the last assessment point. Regarding attention, a fluctuating effect was found, while for memory, the fact that the two groups started with a group difference confounded the results. For wakefulness there was no significant effect in any particular assessment point, while for emotional processing and executive functions, the small number of studies did not allow for any effect to emerge. In summary, no consistent evidence for enhancing effects of antidepressants could be found. There is little evidence so far to support the popular opinion that antidepressants have a positive effect on the mood of healthy individuals after repeated administration. No evidence of a significant adverse event profile could be found. The studies included in this systematic review not only provide insufficient evidence for or against any effect in healthy people, but they are inapt to be used for answering this question. This may be explained by the fact that most of them were not designed to examine neuroenhancement effects. The growing public interest in neuroenhancement stands in stark contrast to the paucity of data on enhancement effects of available psychopharmacological agents. | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,631 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesJohn PA Ioannidis (2008). Effectiveness of Antidepressants: An Evidence Myth Constructed From a Thousand Randomized Trials? Philosophy, Ethics, and Humanities in Medicine 3 (1):1-9.
John Davis, William Giakas, Jie Que, Pavan Passad & Stefan Leucht (2011). Should We Treat Depression with Drugs or Psychological Interventions? A Reply to Ioannidis. Philosophy, Ethics, and Humanities in Medicine 6 (1):8-.
Gordon C. S. Smith & Jill P. Pell (2003). Parachute Use to Prevent Death and Major Trauma Related to Gravitational Challenge: Systematic Review of Randomised Controlled Trials. Bmj 327 (7429):1459--61.
H. V. Curran & M. Hildebrandt (1999). Dissociative Effects of Alcohol on Recollective Experience. Consciousness and Cognition 8 (4):497-509.
Thomas R. Weihrauch (2004). Placebo Treatment is Effective Differently in Different Diseases — but is It Also Harmless? A Brief Synopsis. Science and Engineering Ethics 10 (1).
Stanisław Pużyński (2004). Placebo in the Investigation of Psychotropic Drugs, Especially Antidepressants. Science and Engineering Ethics 10 (1).
Werner Ehm (2005). Meta-Analysis O Mind-Matter Experiments: A Statistical Modeling Perspective. Mind and Matter 3 (1):85-132.
Xavier Dumay & Vincent Dupriez (2008). Does the School Composition Effect Matter? Evidence From Belgian Data. British Journal of Educational Studies 56 (4):440 - 477.
Olov Lindahl & Lars Lindwall (1982). Is All Therapy Just a Placebo Effect? Theoretical Medicine and Bioethics 3 (2):255-259.
Philip L. Baird, Pinar Celikkol Geylani & Jeffrey A. Roberts (2012). Corporate Social and Financial Performance Re-Examined: Industry Effects in a Linear Mixed Model Analysis. Journal of Business Ethics 109 (3):367-388.
Janne Chung & Viswanath Umashanker Trivedi (2003). The Effect of Friendly Persuasion and Gender on Tax Compliance Behavior. Journal of Business Ethics 47 (2):133 - 145.
Heungsik Park, Michael T. Rehg & Donggi Lee (2005). The Influence of Confucian Ethics and Collectivism on Whistleblowing Intentions: A Study of South Korean Public Employees. Journal of Business Ethics 58 (4):387 - 403.
Sandra Pellizzoni, Vittorio Girotto & Luca Surian (2010). Beliefs and Moral Valence Affect Intentionality Attributions: The Case of Side Effects. Review of Philosophy and Psychology 1 (2):201-209.
Analytics
Monthly downloads |
Added to index2010-09-14Total downloads15 ( #78,526 of 548,973 )Recent downloads (6 months)1 ( #63,511 of 548,973 )How can I increase my downloads? |
My notes
Discussion
